Skip to main content

Baidu Inc

Exchange: NASDAQSector: Communication ServicesIndustry: Internet Content & Information
Values in USD · ADR · Reports in CNY

Founded in 2000, Baidu's mission is to make the complicated world simpler through technology. Baidu is a leading AI company with strong Internet foundation, trading on Nasdaq under "BIDU" and HKEX under "9888". One Baidu ADS represents eight Class A ordinary shares. SOURCE Baidu, Inc.

Did you know?

Capital expenditures increased by 54% from FY24 to FY25.

Current Price

$125.88

-0.51%

GoodMoat Value

$75.89

39.7% overvalued
Profile
Valuation (TTM)
Market Cap$42.69B
P/E52.15
EV
P/B1.13
Shares Out339.13M
P/Sales2.37
Revenue$18.05B
EV/EBITDA

Baidu Inc (BIDU) Quality Analysis

BIDU GoodMoat Verdict

Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.

BIDU Profitability

Profitability trend analysis coming soon

BIDU Growth

Growth trend analysis coming soon

BIDU Financial Health

Financial health indicators coming soon

BIDU Quality & Fundamental Analysis

Baidu Inc (BIDU) is a Communication Services company in the Internet Content & Information industry, listed on NASDAQ. This quality analysis page evaluates Baidu Inc's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.

Baidu Inc has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 4.19% and a return on equity (ROE) of 2.00%. Return on assets (ROA) stands at 1.19%.

The debt-to-equity ratio is 0.36, with a current ratio of 1.76. Operating margin is -4.51%.

GoodMoat's quality analysis uses AI-powered insights to evaluate whether Baidu Inc is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.